Medicinal Plants Classification Biosynthesis and ... - Index of

Gastroprotective Triterpenoids: Pharmacological Mechanism
[53] Paul-Clark, MJ; Van Cao, T; Moradi-Bidhendi, N; Cooper, D; Gilroy, DW. 15-epilipoxin
A4-mediated induction of nitric oxide explains how aspirin inhibits acute
inflammation. Journal of Experimental Medicine, 2004, 200 (1), 69-78.
[54] Wallace, JL; Menezes de Lima, O; Fiorucci, S. Lipoxins in gastric mucosal health and
disease. Prostaglandin, Leukotrienes and Essential Fatty Acids, 2005, 73, 251-255.
[55] Arita, M; Clish, CB; Serhan, CN. The contributions of aspirin and microbial oxygenase
to the biosynthesis of anti-inflammatory resolvins: novel oxygenase products from ω-3
polyunsaturated fatty acids. Biochemical and Biophysical Reasearch Communications,
2005, 338, 149-157.
[56] Garavito, RM; Malkowski, MG; Dewitt, DL. The structures of prostaglandin
endoperoxide H synthases-1 and -2. Prostaglandins other Lipid Mediators, 2002, 68-
69, 129-152.
[57] Serhan, CN; Clish, CB; Brannon, J; Colgan, SP; Chiang, N; Gronert, K. Novel
functional sets of lipid-derived mediators with anti-inflammatory actions generated
from omega-3 fatty acids via cyclooxygenase 2-nonsteroidal anti-inflammatory drugs
and transcellular processing. The Journal of Experimental Medicine, 2000, 192(8),
1197-1204.
[58] Arita, M; Yoshida, M; Hong, S; Tjonahen, E; Glickman, JN; Petasis, NA; Blumberg,
RS; Serhan, CN. Resolvin E1, an endogenous lipid mediator derived from omega-3
eicosapentaenoic acid, protects against 2,4,6-trinitrobenzene sulfonic acid-induced
colitis. Proceedings of the National Academy of Sciences, 2005, 102(21), 7671-7676.
[59] Wang, R. Two´s company, three´s a crowd: can H2S be the third endogenous gaseous
mediator? FASEB Journal, 2002, 16, 1792-1798.
[60] Kasparek, MS; Linden, DR; Kreis, ME; Sarr, MG. Gasotransmitters in the
gastrointestinal tract. Surgery, 2008, 143(4), 455-459.
[61] Iwata, F; Koo, A; Itoh, M; Lam, K; Leung, JW; Leung, FW. Functional evidence
linking potassium channels and afferent nerve-mediated mucosal protection in rat
stomach. Life Sciences, 1997, 61, 1713-1720.
[62] Fiorucci, S; Orlandi, S: Mencarelli, A; Caliendo, G; Santagada, V; Distrutti, E;
Santucci, L; Cirino, G; Wallace, JL. Enhanced activity of a hydrogen sulphidereleasing
derivative of mesalamine (ATB-429) in a mouse model of colitis. British
Journal of Pharmaoclogy, 2007, 150, 996-1002.
[63] Distrutti, E; Sediari, L; Mencarelli, A; Renga, B; Orlandi, S; Russo, G; Caliendo G,
Santagada V, Cirino G, Wallace JL, Fiorucci S. 5-amino-2-hydroxybenzoic acid 4-(5thioxo-5H-[1,2]
dithiol-3yl)-phenyl ester (ATB-429), a hydrogen sulfide-releasing
derivative of mesalamine, exerts antinociceptive effects in a model of postinflammatory
hypersensitivity. Journal of Pharmacology and Experimental Therapeutics, 2006,
319, 447-458.
[64] Yonezawa, D; Sekiguchi, F; Miyamoto, M; Taniguchi, E; Honjo, M; Masuko, T;
Nishikawa, H; Kawabata, A. A protective role of hydrogen sulfide against oxidative
stress in rat gastric mucosal epithelium. Toxicology, 2007, 241, 11-18.
[65] Kowicka, E; Beltowski, J. Hydrogen sulfide (H2S)- the third gas of interest for
pharmacologists. Pharmacological Reports, 2007, 59, 4-24.
131